Back to today’s briefing

Story perspectives

FDA Unveils 2025-26 Flu Vaccine Recommendations Without Advisory Input

3/14/2025

50 11

Summary

Story summary

The FDA has unveiled its flu vaccine recommendations for the 2025-26 season, endorsing a trivalent vaccine that targets two influenza A strains and one B strain. This pivotal decision came without the guidance of its independent advisory committee, whose meeting was unexpectedly canceled, yet it remains in harmony with the World Health Organization's advice.

1 of 1

Story summary

The FDA has unveiled its flu vaccine recommendations for the 2025-26 season, endorsing a trivalent vaccine that targets two influenza A strains and one B strain. This pivotal decision came without the guidance of its independent advisory committee, whose meeting was unexpectedly canceled, yet it remains in harmony with the World Health Organization's advice.